Predominance of Th2 response in human abdominal aortic aneurysm: Mistaken identity for IL-4-producing NK and NKT cells?

Cellular Immunology

Volumn 233, Issue 2, 2005, Pages 109-114

  Chan, Woon Ling ^a   Pejnovic, Nada ^a   Liew, Tze Vun ^a   Hamilton, Hamish ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Abdominal aortic aneurysm; NK cells; NKT

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CELL MARKER; INTERLEUKIN 4; INTERLEUKIN 5;

ABDOMINAL AORTA ANEURYSM; ANGIOGENESIS; ARTERY DILATATION; AUTOIMMUNITY; CELL INFILTRATION; CELLULAR IMMUNITY; CHRONIC INFLAMMATION; CONFERENCE PAPER; CYTOKINE PRODUCTION; DISEASE COURSE; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; LYMPHOID CELL; MACROPHAGE; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TH2 CELL; TRANSPLANTATION;

AORTIC ANEURYSM, ABDOMINAL; BIOLOGICAL MARKERS; HUMANS; INTERLEUKIN-4; KILLER CELLS, NATURAL; TH2 CELLS;

EID: 23044496109     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellimm.2005.04.020     Document Type: Conference Paper

References (57)

1. L.M. Prisant, and J.S. Mondy III Abdominal aortic aneurysm J. Clin. Hypertens. (Greenwich) 6 2004 85 89
2. J.R. Cohen, I. Sarfati, D. Danna, and L. Wise Smooth muscle cell elastase, atherosclerosis, and abdominal aortic aneurysms Ann. Surg. 216 1992 327 330 discussion 322-330
3. R.W. Thompson Basic science of abdominal aortic aneurysms: emerging therapeutic strategies for an unresolved clinical problem Curr. Opin. Cardiol. 11 1996 504 518
4. S.T. MacSweeney, J.T. Powell, and R.M. Greenhalgh Pathogenesis of abdominal aortic aneurysm Br. J. Surg. 81 1994 935 941
5. L.A. Anderson An update on the cause of abdominal aortic aneurysms J. Vasc. Nurs. 12 1994 95 100
6. V.J. Halpern, M. Mathrumbutham, C. Lagraize, S.K. Rao, G.R. Faust, and J.R. Cohen Reduced protease inhibitory capacity in patients with abdominal aortic aneurysms is reversed with surgical repair J. Vasc. Surg. 35 2002 792 797
7. M.P. Jacob Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions Biomed. Pharmacother. 57 2003 195 202
8. P.K. Shah Inflammation, metalloproteinases, and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm Circulation 96 1997 2115 2117
9. P.B. Dobrin, and R. Mrkvicka Failure of elastin or collagen as possible critical connective tissue alterations underlying aneurysmal dilatation Cardiovasc. Surg. 2 1994 484 488
10. A. Lopez-Candales, D.R. Holmes, S. Liao, M.J. Scott, S.A. Wickline, and R.W. Thompson Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms Am. J. Pathol. 150 1997 993 1007
11. R.W. Thompson, S. Liao, and J.A. Curci Vascular smooth muscle cell apoptosis in abdominal aortic aneurysms Coron. Artery Dis. 8 1997 623 631
12. M.R. Bennett, K. Macdonald, S.W. Chan, J.J. Boyle, and P.L. Weissberg Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques Circ. Res. 82 1998 704 712
13. D.R. Holmes, S. Liao, W.C. Parks, and R.W. Thompson Medial neovascularization in abdominal aortic aneurysms: a histopathologic marker of aneurysmal degeneration with pathophysiologic implications J. Vasc. Surg. 21 1995 761 771 (discussion 762-771)
14. M.M. Thompson, L. Jones, A. Nasim, R.D. Sayers, and P.R. Bell Angiogenesis in abdominal aortic aneurysms Eur. J. Vasc. Endovasc. Surg. 11 1996 464 469
15. Z. Werb, T.H. Vu, J.L. Rinkenberger, and L.M. Coussens Matrix-degrading proteases and angiogenesis during development and tumor formation APMIS 107 1999 11 18
16. C. Sunderkotter, K. Steinbrink, M. Goebeler, R. Bhardwaj, and C. Sorg Macrophages and angiogenesis J. Leukoc. Biol. 55 1994 410 422
17. M. Kunecki, and A. Nawrocka Elastin-laminin receptor and abdominal aortic aneurysms. New subject to study? A review Pathol. Biol. (Paris) 49 2001 333 338
18. G.W. Sullivan, I.J. Sarembock, and J. Linden The role of inflammation in vascular diseases J. Leukoc. Biol. 67 2000 591 602
19. T. Freestone, R.J. Turner, A. Coady, D.J. Higman, R.M. Greenhalgh, and J.T. Powell Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm Arterioscler. Thromb. Vasc. Biol. 15 1995 1145 1151
20. K.M. Newman, J. Jean-Claude, H. Li, W.G. Ramey, and M.D. Tilson Cytokines that activate proteolysis are increased in abdominal aortic aneurysms Circulation 90 1994 II224 II227
21. P. Carmeliet, L. Moons, R. Lijnen, M. Baes, V. Lemaitre, P. Tipping, A. Drew, Y. Eeckhout, S. Shapiro, F. Lupu, and D. Collen Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation Nat. Genet. 17 1997 439 444
22. R.W. Thompson, D.R. Holmes, R.A. Mertens, S. Liao, M.D. Botney, R.P. Mecham, H.G. Welgus, and W.C. Parks Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages J. Clin. Invest. 96 1995 318 326
23. J.A. Curci, S. Liao, M.D. Huffman, S.D. Shapiro, and R.W. Thompson Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms J. Clin. Invest. 102 1998 1900 1910
24. K.M. Newman, J. Jean-Claude, H. Li, J.V. Scholes, Y. Ogata, H. Nagase, and M.D. Tilson Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall J. Vasc. Surg. 20 1994 814 820
25. S. Saito, N. Zempo, A. Yamashita, H. Takenaka, K. Fujioka, and K. Esato Matrix metalloproteinase expressions in arteriosclerotic aneurysmal disease Vasc. Endovasc. Surg. 36 2002 1 7
26. C.M. Dollery, C.A. Owen, G.K. Sukhova, A. Krettek, S.D. Shapiro, and P. Libby Neutrophil elastase in human atherosclerotic plaques: production by macrophages Circulation 107 2003 2829 2836
27. U. Schonbeck, F. Mach, G.K. Sukhova, C. Murphy, J.Y. Bonnefoy, R.P. Fabunmi, and P. Libby Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture? Circ. Res. 81 1997 448 454
28. B.G. Halloran, and B.T. Baxter Pathogenesis of aneurysms Semin. Vasc. Surg. 8 1995 85 92
29. A.E. Koch, G.K. Haines, R.J. Rizzo, J.A. Radosevich, R.M. Pope, P.G. Robinson, and W.H. Pearce Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response Am. J. Pathol. 137 1990 1199 1213
30. E.L. Henderson, Y.J. Geng, G.K. Sukhova, A.D. Whittemore, J. Knox, and P. Libby Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms Circulation 99 1999 96 104
31. U. Schonbeck, G.K. Sukhova, N. Gerdes, and P. Libby T (H)2 predominant immune responses prevail in human abdominal aortic aneurysm Am. J. Pathol. 161 2002 499 506
32. K. Shimizu, M. Shichiri, P. Libby, R.T. Lee, and R.N. Mitchell Th2-predominant inflammation and blockade of IFN-gamma signaling induce aneurysms in allografted aortas J. Clin. Invest. 114 2004 300 308
33. A. Erlebacher Why isn't the fetus rejected? Curr. Opin. Immunol. 13 2001 590 593
34. W.J. Murphy, C.Y. Koh, A. Raziuddin, M. Bennett, and D.L. Longo Immunobiology of natural killer cells and bone marrow transplantation: merging of basic and preclinical studies Immunol. Rev. 181 2001 279 289
35. W.L. Chan, N. Pejnovic, C.A. Lee, and N.A. Al-Ali Human IL-18 receptor and ST2L are stable and selective markers for the respective type 1 and type 2 circulating lymphocytes J. Immunol. 167 2001 1238 1244
36. T.P. Plackett, E.D. Boehmer, D.E. Faunce, and E.J. Kovacs Aging and innate immune cells J. Leukoc. Biol. 76 2004 291 299
37. K.J. Hammond, and D.I. Godfrey NKT cells: potential targets for autoimmune disease therapy? Tissue Antigens 59 2002 353 363
38. H.R. MacDonald Development and selection of NKT cells Curr. Opin. Immunol. 14 2002 250 254
39. M.J. Smyth, N.Y. Crowe, Y. Hayakawa, K. Takeda, H. Yagita, and D.I. Godfrey NKT cells-conductors of tumor immunity Curr. Opin. Immunol. 14 2002 165 171
40. A. Bendelac, M.N. Rivera, S.H. Park, and J.H. Roark Mouse CD1-specific NK1 T cells: development, specificity, and function Annu. Rev. Immunol. 15 1997 535 562
41. T. Takahashi, M. Nieda, Y. Koezuka, A. Nicol, S.A. Porcelli, Y. Ishikawa, K. Tadokoro, H. Hirai, and T. Juji Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells J. Immunol. 164 2000 4458 4464
42. J.R. Ortaldo, and R.B. Herberman Heterogeneity of natural killer cells Annu. Rev. Immunol. 2 1984 359 394
43. G. Trinchieri Biology of natural killer cells Adv. Immunol. 47 1989 187 376
44. T. Kawano, J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, H. Sato, E. Kondo, M. Harada, H. Koseki, T. Nakayama, Y. Tanaka, and M. Taniguchi Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells Proc. Natl. Acad. Sci. USA 95 1998 5690 5693
45. S.B. Wilson, S.C. Kent, K.T. Patton, T. Orban, R.A. Jackson, M. Exley, S. Porcelli, D.A. Schatz, M.A. Atkinson, S.P. Balk, J.L. Strominger, and D.A. Hafler Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes Nature 391 1998 177 181
46. H. Kitamura, K. Iwakabe, T. Yahata, S. Nishimura, A. Ohta, Y. Ohmi, M. Sato, K. Takeda, K. Okumura, L. Van Kaer, T. Kawano, M. Taniguchi, and T. Nishimura The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)- 12 production by dendritic cells and IL-12 receptor expression on NKT cells J. Exp. Med. 189 1999 1121 1128
47. T. Yoshimoto, A. Bendelac, C. Watson, J. Hu-Li, and W.E. Paul Role of NK1.1+ T cells in a TH2 response and in immunoglobulin E production Science 270 1995 1845 1847
48. N. Burdin, L. Brossay, and M. Kronenberg Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis Eur. J. Immunol. 29 1999 2014 2025
49. D. Xu, W.L. Chan, B.P. Leung, D. Hunter, K. Schulz, R.W. Carter, I.B. McInnes, J.H. Robinson, and F.Y. Liew Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells J. Exp. Med. 188 1998 1485 1492
50. D. Xu, W.L. Chan, B.P. Leung, F. Huang, R. Wheeler, D. Piedrafita, J.H. Robinson, and F.Y. Liew Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells J. Exp. Med. 187 1998 787 794
51. E. Tupin, A. Nicoletti, R. Elhage, M. Rudling, H.G. Ljunggren, G.K. Hansson, and G.P. Berne CD1d-dependent activation of NKT cells aggravates atherosclerosis J. Exp. Med. 199 2004 417 422 Epub 2004 Jan 2026
52. W.L. Chan, N. Pejnovic, T.V. Liew, C.A. Lee, R. Groves, and H. Hamilton NKT cell subsets in infection and inflammation Immunol. Lett. 85 2003 159 163
53. T. Sasaguri, N. Arima, A. Tanimoto, S. Shimajiri, T. Hamada, and Y. Sasaguri A role for interleukin 4 in production of matrix metalloproteinase 1 by human aortic smooth muscle cells Atherosclerosis 138 1998 247 253
54. C. Chizzolini, R. Rezzonico, C. De Luca, D. Burger, and J.M. Dayer Th2 cell membrane factors in association with IL-4 enhance matrix metalloproteinase-1 (MMP-1) while decreasing MMP-9 production by granulocyte-macrophage colony-stimulating factor-differentiated human monocytes J. Immunol. 164 2000 5952 5960
55. Y. Zhang, K. McCluskey, K. Fujii, and L.M. Wahl Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms J. Immunol. 161 1998 3071 3076
56. S.B. Wilson, S.C. Kent, H.F. Horton, A.A. Hill, P.L. Bollyky, D.A. Hafler, J.L. Strominger, and M.C. Byrne Multiple differences in gene expression in regulatory Valpha 24Jalpha Q T cells from identical twins discordant for type I diabetes Proc. Natl. Acad. Sci. USA 97 2000 7411 7416
57. R. Gausling, C. Trollmo, and D.A. Hafler Decreases in interleukin-4 secretion by invariant CD4(-)CD8(-)V alpha 24J alpha Q T cells in peripheral blood of patients with relapsing-remitting multiple sclerosis Clin. Immunol. 98 2001 11 17